News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

iCAD, Inc. (ICAD) Reports Growing Adoption And Utilization Of Its Xoft System For Breast And Skin Cancers


11/20/2013 9:19:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand, adoption and clinical evidence for its Xoft® Axxent® Electronic Brachytherapy System® for the treatment of early-stage breast cancer and non-melanoma skin cancer.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES